Author

H. G. Russnes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Birbrair· 1 shared A. Helland· 1 shared A. R. Nobre· 1 shared A. Saetersdal· 1 shared A. Trinh· 1 shared A.-L. Borresen-Dale· 1 shared B. Naume· 1 shared D. K. Singh· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Birbrair

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NG2+/Nestin+ mesenchymal stem cells dictate DTC dormancy in the bone marrow through TGFβ2

A. R. Nobre, E. Risson, D. K. Singh, J. S. Di Martino, J. F. Cheung, J. Wang, J. Johnson, H. G. Russnes, J. J. Bravo-Cordero, A. Birbrair, B. Naume, M. Azhar, P. S. Frenette, J. A. Aguirre-Ghiso

This study shows NG2+/Nestin+ mesenchymal stem cells in the bone marrow use TGFβ2 to induce dormancy in breast cancer disseminated tumor cells.

bioRxiv · Oct 22, 2020Cancer Biology

Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumors

I. H. Rye, A. Trinh, A. Saetersdal, D. Nebdal, O. C. Lingjaerde, V. Almendro, K. Polyak, A.-L. Borresen-Dale, A. Helland, F. Markowetz, H. G. Russnes

This study examines how intra-tumor heterogeneity in HER2 expression and copy number affects treatment outcomes in HER2+ breast cancer patients.

bioRxiv · Apr 18, 2018Cancer Biology